SG11202011163SA - Nucleic acid for treating mite allergy - Google Patents
Nucleic acid for treating mite allergyInfo
- Publication number
- SG11202011163SA SG11202011163SA SG11202011163SA SG11202011163SA SG11202011163SA SG 11202011163S A SG11202011163S A SG 11202011163SA SG 11202011163S A SG11202011163S A SG 11202011163SA SG 11202011163S A SG11202011163S A SG 11202011163SA SG 11202011163S A SG11202011163S A SG 11202011163SA
- Authority
- SG
- Singapore
- Prior art keywords
- nucleic acid
- mite allergy
- treating mite
- treating
- allergy
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22065—Peptidase 1 (mite) (3.4.22.65)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/06—Fusion polypeptide containing a localisation/targetting motif containing a lysosomal/endosomal localisation signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018091963 | 2018-05-11 | ||
| PCT/JP2019/018657 WO2019216394A1 (en) | 2018-05-11 | 2019-05-10 | Nucleic acid for treating mite allergy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011163SA true SG11202011163SA (en) | 2020-12-30 |
Family
ID=68468077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011163SA SG11202011163SA (en) | 2018-05-11 | 2019-05-10 | Nucleic acid for treating mite allergy |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20210163957A1 (en) |
| EP (1) | EP3795688A4 (en) |
| JP (1) | JPWO2019216394A1 (en) |
| KR (1) | KR20210007977A (en) |
| CN (1) | CN112105735A (en) |
| AR (1) | AR115379A1 (en) |
| AU (1) | AU2019268022A1 (en) |
| BR (1) | BR112020023041A2 (en) |
| CA (1) | CA3099495A1 (en) |
| CO (1) | CO2020013967A2 (en) |
| JO (1) | JOP20200285A1 (en) |
| MA (1) | MA52634A (en) |
| MX (1) | MX2020012057A (en) |
| PH (1) | PH12020551876A1 (en) |
| SG (1) | SG11202011163SA (en) |
| TW (1) | TW202003542A (en) |
| WO (1) | WO2019216394A1 (en) |
| ZA (1) | ZA202006984B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202011163SA (en) * | 2018-05-11 | 2020-12-30 | Astellas Pharma Inc | Nucleic acid for treating mite allergy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS587994B2 (en) | 1977-09-22 | 1983-02-14 | エプソン株式会社 | liquid crystal display device |
| KR900002146B1 (en) | 1987-02-27 | 1990-04-02 | 금성전선 주식회사 | Sorption type hot and cold water supplier |
| AU624077B2 (en) | 1987-06-17 | 1992-06-04 | Institute For Child Health Research | Cloning of mite allergens |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5633234A (en) | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
| JP2004083812A (en) | 2002-08-28 | 2004-03-18 | Catalysts & Chem Ind Co Ltd | Coating liquid for forming transparent film, substrate having transparent coating film and display device |
| WO2004019978A1 (en) | 2002-08-29 | 2004-03-11 | National University Of Singapore | Recombinant nucleic acid useful for inducing protective immune response against allergens |
| JP4072549B2 (en) | 2005-10-31 | 2008-04-09 | 株式会社エヌ・ティ・ティ・ドコモ | Voice quality confirmation system and voice quality confirmation method |
| AT503530A1 (en) | 2006-04-28 | 2007-11-15 | Biomay Ag | POLYPEPTIDE WITH ALLERGENIC PROPERTIES |
| EP2042193A1 (en) | 2007-09-28 | 2009-04-01 | Biomay AG | RNA Vaccines |
| US20160185831A1 (en) | 2011-06-14 | 2016-06-30 | Immunomic Therapeutics, Inc. | Nucleic acids for treatment of allergies |
| TWI548982B (en) | 2012-03-06 | 2016-09-11 | 宏碁股份有限公司 | Management methods and related computer systems and computer program products thereof |
| BR112014031327B1 (en) * | 2012-06-15 | 2022-02-01 | Immunomic Therapeutics, Inc | Nucleic acid molecules for the treatment of allergies |
| CA2914037A1 (en) | 2013-06-06 | 2014-12-11 | Anergis S.A. | Contiguous overlapping peptides for treatment of house dust mites allergy |
| JP2015200357A (en) | 2014-04-07 | 2015-11-12 | 本田技研工業株式会社 | Vehicle power transmission device |
| CN106459994A (en) | 2014-06-23 | 2017-02-22 | 免疫治疗有限公司 | Nucleic acids for treatment of peanut allergies |
| EP3228628B1 (en) * | 2014-12-02 | 2021-08-18 | Taiho Pharmaceutical Co., Ltd. | Novel dermatophagoides farinae protein |
| EP3541420A2 (en) | 2016-11-16 | 2019-09-25 | Immunomic Therapeutics, Inc. | Nucleic acids for treatment of allergies |
| SG11202011163SA (en) * | 2018-05-11 | 2020-12-30 | Astellas Pharma Inc | Nucleic acid for treating mite allergy |
-
2019
- 2019-05-10 SG SG11202011163SA patent/SG11202011163SA/en unknown
- 2019-05-10 MA MA052634A patent/MA52634A/en unknown
- 2019-05-10 CA CA3099495A patent/CA3099495A1/en active Pending
- 2019-05-10 TW TW108116252A patent/TW202003542A/en unknown
- 2019-05-10 MX MX2020012057A patent/MX2020012057A/en unknown
- 2019-05-10 EP EP19799639.0A patent/EP3795688A4/en not_active Withdrawn
- 2019-05-10 AU AU2019268022A patent/AU2019268022A1/en not_active Abandoned
- 2019-05-10 WO PCT/JP2019/018657 patent/WO2019216394A1/en active Application Filing
- 2019-05-10 AR ARP190101246A patent/AR115379A1/en unknown
- 2019-05-10 CN CN201980031254.0A patent/CN112105735A/en active Pending
- 2019-05-10 US US17/054,340 patent/US20210163957A1/en not_active Abandoned
- 2019-05-10 BR BR112020023041-3A patent/BR112020023041A2/en unknown
- 2019-05-10 KR KR1020207032129A patent/KR20210007977A/en active Search and Examination
- 2019-05-10 JO JOP/2020/0285A patent/JOP20200285A1/en unknown
- 2019-05-10 JP JP2020518342A patent/JPWO2019216394A1/en active Pending
-
2020
- 2020-11-06 PH PH12020551876A patent/PH12020551876A1/en unknown
- 2020-11-09 CO CONC2020/0013967A patent/CO2020013967A2/en unknown
- 2020-11-10 ZA ZA2020/06984A patent/ZA202006984B/en unknown
-
2021
- 2021-07-15 US US17/377,297 patent/US11312966B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202006984B (en) | 2022-03-30 |
| KR20210007977A (en) | 2021-01-20 |
| AR115379A1 (en) | 2021-01-13 |
| AU2019268022A1 (en) | 2020-11-26 |
| TW202003542A (en) | 2020-01-16 |
| CO2020013967A2 (en) | 2021-02-08 |
| MA52634A (en) | 2021-03-24 |
| EP3795688A1 (en) | 2021-03-24 |
| CN112105735A (en) | 2020-12-18 |
| BR112020023041A2 (en) | 2021-02-09 |
| PH12020551876A1 (en) | 2021-05-31 |
| EP3795688A4 (en) | 2022-01-19 |
| JPWO2019216394A1 (en) | 2021-05-27 |
| MX2020012057A (en) | 2021-01-29 |
| US11312966B2 (en) | 2022-04-26 |
| US20210340549A1 (en) | 2021-11-04 |
| WO2019216394A1 (en) | 2019-11-14 |
| US20210163957A1 (en) | 2021-06-03 |
| JOP20200285A1 (en) | 2020-11-09 |
| CA3099495A1 (en) | 2019-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1248284A1 (en) | Multiple-emulsion nucleic acid amplification | |
| SG11201911430PA (en) | Novel nucleic acid molecules | |
| EP3472359A4 (en) | Nucleic acid sequencing | |
| IL254000A0 (en) | Nucleic acid sequence assembly | |
| HK1243958A1 (en) | Nucleic acid construct | |
| GB201507119D0 (en) | Nucleic Acid Construct | |
| HK1244021A1 (en) | Nucleic acid construct | |
| IL271239A (en) | Nucleic acid indexing techniques | |
| GB201507115D0 (en) | Nucleic Acid Construct | |
| GB201507111D0 (en) | Nucleic acid construct | |
| IL277472A (en) | Nucleic acid molecules for pseudouridylation | |
| GB201621271D0 (en) | Method for nucleic acid depletion | |
| GB2589159B (en) | Nucleic acid sequencing apparatus | |
| HK1250682A1 (en) | Nucleic acid amplification | |
| EP3619311C0 (en) | Dna assembly | |
| GB201812474D0 (en) | Nucleic acid construct | |
| ZA202100242B (en) | Recombinant nucleic acid construct | |
| GB201517241D0 (en) | DNA modification | |
| ZA202006984B (en) | Nucleic acid for treating mite allergy | |
| GB201818816D0 (en) | Regulatory nucleic acid sequences | |
| RS64086B1 (en) | Nucleic acid sequencing method | |
| GB201609115D0 (en) | Isolating nucleic acids | |
| ZA202006985B (en) | Nucleic acid for treating crustacean allergy | |
| GB201913898D0 (en) | Nucleic acid construct | |
| PT3833786T (en) | Recombinant nucleic acid construct |